查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1944453

全球药物输送笔和注射器市场（按产品、治疗用途、最终用途、国家和地区划分）－产业分析、市场规模、份额和预测（2025-2032年）

Pen And Injector Drug Delivery Devices Market, By Product, By Therapeutic Use, By End Use, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 321 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计到 2024 年，药物输送笔和注射器设备市场规模将达到 1,138.9756 亿美元，从 2025 年到 2032 年的复合年增长率为 9.81%。

医疗专业人员使用输液笔和注射器作为专用设备，透过皮下或肌肉注射为患者提供精确的药物剂量，同时确保使用者安全和药物管理。这些设备由基本组件构成——手动和电子输液笔以及预装特定药物的自动注射器——帮助患者学习如何在家中进行自行注射。这些设备用于治疗慢性病和急性疾病，包括糖尿病、肥胖、自体免疫疾病、荷尔蒙缺乏症和过敏性休克，这些疾病都需要患者透过定期注射接受精确的药物剂量。与传统的管瓶和注射器注射方式结合使用时，输液笔和注射器可以减少操作错误，并减轻患者的疼痛和焦虑。这提高了患者居家照护治疗的依从性，并使其成为现代注射疗法（包括生物製剂和特殊药物）的首选给药系统。

笔式和注射器式给药装置的市场动态

慢性病发生率呈上升趋势

慢性病发病率的不断上升是推动注射笔和注射器等给药装置市场扩张的主要因素，因为越来越多的患者需要持续、精准的注射药物治疗。糖尿病、肥胖症、自体免疫疾病、心血管疾病和荷尔蒙失衡等患者都需要注射药物来控制病情，这使得使用者对易于操作的给药系统的需求持续增长。注射笔和注射器等装置能够让使用者根据精确的剂量资讯自行给药，与传统注射器相比，疗效更佳。这对于需要终身持续治疗的患者尤其重要。对于医疗保健系统和製药公司而言，注射笔和注射器等装置是居家医疗的理想解决方案。患者可以在家中接受治疗，减少就医次数，其使用有助于改善患者健康状况，从而进一步推动市场扩张。

笔式和注射器式给药装置市场：細項分析

副产品

截至2024年，注射器式註射剂占据了最大的市场份额。该行业的成长主要得益于类风湿性关节炎、多发性硬化症和糖尿病等慢性疾病患者对易于使用的居家自行注射设备的需求。自动注射器凭藉其人性化的设计和带有自动给药系统的隐藏式针头，提供了一种便捷、安全、可靠的给药方式，有效避免了注射错误并减轻了针刺疼痛。随着患者越来越倾向于自我给药，以及生物製药技术的进步创造了新的机会，自动注射器的全球使用量正在不断增长。 2025年10月，肖特製药（SCHOTT Pharma）透过其syriQ BioPure平台推出了一款5.5毫升大容量预灌封式玻璃注射器，该注射器配备一体式针头。这款新型注射器可与Ypsomed公司的YpsoMate 5.5大容量自动注射器配合使用，使患者能够在家中安全便捷地註射生物製药。以使用者为中心的设计和安全创新将提高可靠性和合规性，使其成为製造商和医疗保健机构关注的关键目标。

药物输送笔和注射器装置市场—区域分析

北美地区正经历显着的收入成长。现有的医疗保健系统、先进的基础设施以及创新性的研发活动正在推动该产业的扩张。由于糖尿病和癌症等慢性疾病患者人数众多，市场持续成长。乳癌。乳癌情况迫切需要开发可靠且易于患者使用的给药方法。政府法规，以及FDA等机构（负责监管预填充注射笔和自动注射器）的严格品质要求，为先进设备的广泛应用创造了有利条件。 2025年2月，FDA核准了首个速效胰岛素生物相似药Melilog。本产品有两种规格：3毫升预填充笔和10毫升多剂量管瓶。这项研究表明，监管支持可以帮助更多人获得注射笔治疗。製药公司与监管机构之间的持续合作将进一步支持北美地区的创新、市场成长和患者疗效的改善。

目录

第一章 注射笔和注射器给药装置市场概述

  • 分析范围
  • 市场估算期

第二章执行摘要

  • 市场区隔
  • 竞争考察

第三章 笔式和注射器式给药装置的主要市场趋势

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 未来市场趋势

4. 注射笔和注射器给药装置市场：产业分析

  • PEST分析
  • 波特五力分析
  • 市场成长展望：概览
  • 管理体制分析

5. 注射笔和注射器给药装置市场：地缘政治紧张局势加剧的影响

  • 新冠疫情的影响
  • 俄乌战争的影响
  • 中东衝突的影响

第六章 笔式和注射器式给药装置的市场现状

  • 笔式和注射器式给药装置市场份额分析（2024 年）
  • 主要製造商的细分数据
    • 对现有公司的分析
    • 新兴企业分析

7. 按产品分類的笔式和注射器式给药装置市场

  • 概述
    • 细分市场占有率分析：依产品划分
    • 喷油嘴型
      • GLP-1促效剂
      • 荷尔蒙疗法
      • 生物製药
      • 其他的
    • 笔型
      • GLP-1促效剂
      • 胰岛素
      • 荷尔蒙疗法
      • 其他的

8. 依治疗用途分類的笔式和注射器式药物输送装置市场

  • 概述
    • 细分市场占有率分析：依治疗用途划分
    • 自体免疫疾病
    • 糖尿病
    • 肿瘤学
    • 肥胖
    • 内分泌疾病
    • 其他的

9. 依最终用途分類的笔式和注射器式药物输送装置市场

  • 概述
    • 细分市场占有率分析：依最终用途划分
    • 居家医疗环境
    • 医院
    • 其他的

10. 按地区分類的笔式和注射器式药物输送装置市场

  • 介绍
  • 北美洲
    • 概述
    • 北美主要製造商
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲主要製造商
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 瑞典
    • 俄罗斯
    • 波兰
    • 其他的
  • 亚太地区
    • 概述
    • 亚太地区主要製造商
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 菲律宾
    • 其他的
  • 拉丁美洲
    • 概述
    • 拉丁美洲主要製造商
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 其他的
  • 中东和非洲（MEA）
    • 概述
    • 中东和非洲的主要製造商
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • 其他的

第十一章 主要供应商分析－笔式和注射器式给药装置产业

  • 竞争对手仪錶板
    • 竞争基准
    • 竞争定位
  • 公司简介
    • Amgen, Inc.
    • Merck KGaA
    • Eli Lilly and Company
    • AstraZeneca plc
    • Pfizer, Inc.
    • Sanofi
    • Teva Pharmaceuticals
    • Novo Nordisk A/S
    • Ferring Pharmaceuticals
    • AbbVie Inc.

第十二章：分析师视角360度分析

简介目录
Product Code: ANV6034

The Pen And Injector Drug Delivery Devices Market size was valued at US$113,897.56 Million in 2024, expanding at a CAGR of 9.81% from 2025 to 2032.

Medical professionals use pen and injector drug delivery devices as special equipment which enables them to deliver exact medication amounts into patients through subcutaneous or intramuscular injections while ensuring user safety and medication control. The devices operate through their basic components, which include both manual and electronic injection pens and autoinjectors that come prefilled with specific medications to help patients learn how to inject themselves at home. People use the devices for both chronic and acute medical conditions which include diabetes, obesity and autoimmune disorders and hormonal deficiencies and anaphylaxis because these conditions require patients to receive precise medication doses through scheduled injections. The use of pen and injector drug delivery devices together with traditional vial-and-syringe methods achieves better dosing accuracy because it decreases handling mistakes while providing patients with less painful and anxious injections, thus enhancing patient treatment compliance through home care, which leads to their selection as the primary drug delivery system for modern injectable treatments, including biologics and specialty pharmaceuticals.

Pen And Injector Drug Delivery Devices Market- Market Dynamics

Rising prevalence of chronic diseases

The increasing occurrence of chronic diseases serves as the primary reason for market expansion of pen and injector drug delivery devices because more patients require continuous and precise delivery of injectable medical treatments. Patients with diabetes and obesity and autoimmune disorders and cardiovascular diseases and hormonal imbalances require injectable drugs to manage their conditions, which creates a constant need for delivery systems that users can operate easily. Pen and injector devices enable users to administer their medication independently while they receive precise dosage information which leads to better treatment results than patients would achieve through traditional syringe usage, especially when this method becomes essential for patients who need continuous therapy throughout their lives. Pen and injector devices function as the preferred solution for home healthcare in medical systems and pharmaceutical companies because they enable patients to receive treatment at home while decreasing the need for hospital visits and their usage leads to better health results for patients which drives market expansion.

Pen And Injector Drug Delivery Devices Market- Segmentation Analysis:

By Product

In 2024, the injectors segment holds the largest market share. The growth of this industry occurs because patients with chronic diseases such as rheumatoid arthritis, multiple sclerosis, and diabetes demand user-friendly self-injection equipment which allows them to conduct home treatment. Autoinjectors deliver a simple yet secure and dependable delivery method because they include hidden needles with automatic dosage systems and user-friendly designs which help users to avoid mistakes and experience less needle pain. The worldwide use of autoinjectors increases because patients now prefer to administer their medications themselves, while advances in biologics create new opportunities. SCHOTT Pharma introduced a 5.5 ml large-volume prefillable staked-needle glass syringe through its syriQ BioPure platform in October 2025. This new syringe works with Ypsomed's YpsoMate 5.5 large-volume autoinjector, which allows users to safely and easily inject biologic treatments at their homes. User-centric design and safety innovations build confidence and compliance, which makes this area a major target for producers and medical organizations to concentrate their efforts.

Pen And Injector Drug Delivery Devices Market- Geographical Insights

North America region experiences strong revenue growth. The existing healthcare system together with advanced infrastructure and research and development activities with innovative outcomes creates the engine that drives industry expansion. The market experiences growth because many people suffer from chronic diseases which include diabetes and cancer. Breast cancer is one of the most diagnosed cancers among women in the U.S. According to the American Cancer Society, Inc., in 2024, breast cancer was diagnosed in over 310,000 women in the country. The situation requires development of trustworthy delivery methods that patients can easily use. Advanced device usage increases due to government regulations that create favorable conditions together with strict quality requirements from organizations like the FDA which govern prefilled pens and autoinjectors. The FDA approved the first rapid-acting insulin biosimilar Merilog in February 2025 which comes in two formats a 3 ml prefilled pen and a 10 ml multi-dose vial. The study demonstrates that regulatory assistance enables more people to access pen-based injectable therapies. Ongoing collaboration between pharmaceutical companies and regulatory authorities further supports innovation, market growth, and enhanced patient outcomes across North America.

Pen And Injector Drug Delivery Devices Market- Competitive Landscape:

The pen and injector drug-delivery market exists as a competitive sphere which combines two opposing forces. The market consists of pharmaceutical companies that control their entire production process and create their own pen systems together with their exclusive drug portfolio. The market includes specialized device manufacturers and contract manufacturers who create precise engineering solutions and supply special components and custom products. The market predominantly belongs to major pharmaceutical companies which include Novo Nordisk, Eli Lilly, and Sanofi, because they combine their high-demand biologics products with proprietary pen systems. The pharmaceutical industry depends on Becton Dickinson, Ypsomed, SHL Medical, West Pharmaceutical Services, and Gerresheimer for their reusable and disposable platforms, fill-finish interfaces, and outsourced manufacturing capabilities. The market competition develops through strategic partnerships and licensing agreements and mergers and acquisitions because drugmakers require unique user-friendly pen systems that include connected and electronic pens. Device companies expand their product offerings to develop solutions that will help them secure long-term customer contracts. The market faces pricing challenges because of demand uncertainty in developing regions. The market faces heightened competition because of increasing demand for smart pens which provide data collection and adherence services as well as the expansion of GLP-1 pen products throughout different regions. The competition created opportunities for mid-sized contract manufacturers to acquire business from their larger competitors who dominate the market.

Recent Developments:

In October 2025, Stevanato Group S.p.A. announced a major expansion of its drug delivery system manufacturing capacity in Germany. This move strengthens its presence in Europe. The company added over 2,500 square meters of new production space to its Bad Oeynhausen facility. This includes an ISO 8 cleanroom for injection molding and automated assembly. The multi-million-euro investment improves scalability, supply chain resilience, and support for both proprietary and contract manufacturing of drug delivery devices, including autoinjector and pen injector platforms.

In September 2025, Apiject Systems Corp. announced that it had submitted a New Drug Application to the U.S. FDA for the first injectable medicine delivered with its single-dose, single-use prefilled plastic syringe. This submission included glycopyrrolate, which is given through Apiject's special injection device. This device combined Blow-Fill-Seal liquid packaging with precisely molded needle hubs. This platform allowed for scalable and cost-effective manufacturing using materials sourced in the U.S., providing an alternative to standard glass vials and prefilled syringes.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PEN AND INJECTOR DRUG DELIVERY DEVICES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Amgen, Inc.
  • Merck KGaA
  • Eli Lilly and Company
  • AstraZeneca plc
  • Pfizer, Inc.
  • Sanofi
  • Teva Pharmaceuticals
  • Novo Nordisk A/S
  • Ferring Pharmaceuticals
  • AbbVie Inc.

GLOBAL PEN AND INJECTOR DRUG DELIVERY DEVICES MARKET, BY PRODUCT - MARKET ANALYSIS, 2019 - 2032

  • Injectors
  • GLP-1 Agonists
  • Hormone Therapies
  • Biologics
  • Others
  • Pen
  • GLP-1 Agonists
  • Insulin
  • Hormone Therapies
  • Others

GLOBAL PEN AND INJECTOR DRUG DELIVERY DEVICES MARKET, BY THERAPEUTIC USE - MARKET ANALYSIS, 2019 - 2032

  • Autoimmune Disorders
  • Diabetes Mellitus
  • Oncology
  • Obesity
  • Hormonal Disorders
  • Others

GLOBAL PEN AND INJECTOR DRUG DELIVERY DEVICES MARKET, BY END USE - MARKET ANALYSIS, 2019 - 2032

  • Homecare Settings
  • Hospitals
  • Others

GLOBAL Pen And Injector Drug Delivery Devices MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Pen And Injector Drug Delivery Devices Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Pen And Injector Drug Delivery Devices Market Snippet by Product
    • 2.1.2. Pen And Injector Drug Delivery Devices Market Snippet by Therapeutic Use
    • 2.1.3. Pen And Injector Drug Delivery Devices Market Snippet by End Use
    • 2.1.4. Pen And Injector Drug Delivery Devices Market Snippet by Country
    • 2.1.5. Pen And Injector Drug Delivery Devices Market Snippet by Region
  • 2.2. Competitive Insights

3. Pen And Injector Drug Delivery Devices Key Market Trends

  • 3.1. Pen And Injector Drug Delivery Devices Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Pen And Injector Drug Delivery Devices Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Pen And Injector Drug Delivery Devices Market Opportunities
  • 3.4. Pen And Injector Drug Delivery Devices Market Future Trends

4. Pen And Injector Drug Delivery Devices Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Pen And Injector Drug Delivery Devices Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Pen And Injector Drug Delivery Devices Market Landscape

  • 6.1. Pen And Injector Drug Delivery Devices Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Pen And Injector Drug Delivery Devices Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2024&2032 (%)
    • 7.1.2. Injectors
      • 7.1.2.1. GLP-1 Agonists
      • 7.1.2.2. Hormone Therapies
      • 7.1.2.3. Biologics
      • 7.1.2.4. Others
    • 7.1.3. Pen
      • 7.1.3.1. GLP-1 Agonists
      • 7.1.3.2. Insulin
      • 7.1.3.3. Hormone Therapies
      • 7.1.3.4. Others

8. Pen And Injector Drug Delivery Devices Market - By Therapeutic Use

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Therapeutic Use, 2024&2032 (%)
    • 8.1.2. Autoimmune Disorders
    • 8.1.3. Diabetes Mellitus
    • 8.1.4. Oncology
    • 8.1.5. Obesity
    • 8.1.6. Hormonal Disorders
    • 8.1.7. Others

9. Pen And Injector Drug Delivery Devices Market - By End Use

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End Use, 2024&2032 (%)
    • 9.1.2. Homecare Settings
    • 9.1.3. Hospitals
    • 9.1.4. Others

10. Pen And Injector Drug Delivery Devices Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024&2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Pen And Injector Drug Delivery Devices Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 10.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
    • 10.2.5. North America Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
    • 10.2.6. North America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.2.7.4. U.S. Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
      • 10.2.7.5. U.S. Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.2.8.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.2.8.4. Canada Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
      • 10.2.8.5. Canada Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Pen And Injector Drug Delivery Devices Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 10.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
    • 10.3.5. Europe Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
    • 10.3.6. Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.7.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.3.7.4. Germany Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
      • 10.3.7.5. Germany Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.8.3. UK Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.3.8.4. UK Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
      • 10.3.8.5. UK Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.9.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.3.9.4. France Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
      • 10.3.9.5. France Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.10.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.3.10.4. Italy Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
      • 10.3.10.5. Italy Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.11.3. Spain Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.3.11.4. Spain Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
      • 10.3.11.5. Spain Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.13.3. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.3.13.4. Sweden Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
      • 10.3.13.5. Sweden Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.14.3. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.3.14.4. Russia Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
      • 10.3.14.5. Russia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.15.3. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.3.15.4. Poland Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
      • 10.3.15.5. Poland Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Pen And Injector Drug Delivery Devices Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 10.4.4. APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
    • 10.4.5. APAC Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
    • 10.4.6. APAC Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.7.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.4.7.4. China Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
      • 10.4.7.5. China Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.8.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.4.8.4. India Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
      • 10.4.8.5. India Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.9.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.4.9.4. Japan Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
      • 10.4.9.5. Japan Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.4.10.4. South Korea Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
      • 10.4.10.5. South Korea Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.11.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.4.11.4. Australia Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
      • 10.4.11.5. Australia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
      • 10.4.12.5. Indonesia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.13.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.4.13.4. Thailand Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
      • 10.4.13.5. Thailand Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.14.3. PhilippinesMarket Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.4.14.4. Philippines Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
      • 10.4.14.5. Philippines Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Pen And Injector Drug Delivery Devices Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 10.5.4. LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
    • 10.5.5. LATAM Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
    • 10.5.6. LATAM Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.5.7.4. Brazil Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
      • 10.5.7.5. Brazil Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.5.8.4. Mexico Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
      • 10.5.8.5. Mexico Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.5.9.4. Argentina Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
      • 10.5.9.5. Argentina Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.5.10.4. Colombia Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
      • 10.5.10.5. Colombia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Pen And Injector Drug Delivery Devices Key Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 10.6.4. MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
    • 10.6.5. MEA Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
    • 10.6.6. MEA Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.8.3. UAE Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.6.8.4. UAE Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
      • 10.6.8.5. UAE Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.9.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.6.9.4. Israel Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
      • 10.6.9.5. Israel Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.6.10.4. Turkey Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
      • 10.6.10.5. Turkey Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.6.11.4. Algeria Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
      • 10.6.11.5. Algeria Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.6.12.4. Egypt Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
      • 10.6.12.5. Egypt Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Therapeutic Use, 2019 - 2032 (US$ Billion)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)

11. Key Vendor Analysis- Pen And Injector Drug Delivery Devices Industry

  • 11.1. Competitive Dashboard
    • 11.1.1. Competitive Benchmarking
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Amgen, Inc.
    • 11.2.2. Merck KGaA
    • 11.2.3. Eli Lilly and Company
    • 11.2.4. AstraZeneca plc
    • 11.2.5. Pfizer, Inc.
    • 11.2.6. Sanofi
    • 11.2.7. Teva Pharmaceuticals
    • 11.2.8. Novo Nordisk A/S
    • 11.2.9. Ferring Pharmaceuticals
    • 11.2.10. AbbVie Inc.

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us